Home    Back

Depakine    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
102Rubinstein-Taybi syndrome1

102. Rubinstein-Taybi syndrome    [ 3 clinical trials,   8 drugs,   (DrugBank: 1 drug),   7 drug target genes,   17 drug target pathways]
Searched query = "Rubinstein-Taybi syndrome", "RSTS"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 3 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1EUCTR2011-003784-30-FR
(EUCTR)		13/12/2011Rubinstein-Taybi syndrome: approach to functional imaging and therapeutic trialRubinstein-Taybi syndrome: approach to functional imaging and therapeutic trial - RUBIVAL Rubinstein-Taybi Syndrome
MedDRA version: 14.1;Level: PT;Classification code 10039281;Term: Rubinstein-Taybi syndrome;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]		Trade Name: DepakineCHU de bordeauxNULLNAFemale: yes
Male: yes		Phase 2France